Back
to sessions
Sep 29
Scientific
MODERATOR(S)
Benjamin Rosen, PhD, DABR - University of Michigan
Ying Xiao, PhD, FASTRO - University of Pennsylvania
Credits
| AMA PRA Category 1 Credits: | 1.25 |
Presentations
-
12:30pm - 12:40pm ET
From Data to Dialogue: A Real-Time Digital Platform Accelerates Multidisciplinary Decisions in Bone Metastases
Speaker: Manpreet Bedi, MD, MS - Cleveland Clinic Florida, Weston -
12:40pm - 12:50pm ET
Cure Estimation using Reconstructed Kaplan-Meier Analyses in Randomized Phase III Oncology Trials (CUREMA): A Meta-Epidemiological Study
Speaker: Kimi Chauhan, MD, BS, MTM - Mayo Clinic College of Medicine and Science Rochester, Rochester -
12:50pm - 01:00pm ETSpeaker: Tianyuan Dai, PhD - Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
-
01:00pm - 01:10pm ET
Tumor Volume Threshold Identifies Hepatocellular Carcinoma Patients Who Derive Maximal Survival Benefit from Proton Therapy Using Multi-Institutional Causal Machine Learning
Speaker: Ibrahim Chamseddine, PhD - Mass General Brigham, Harvard Medical School, Boston -
01:10pm - 01:20pm ET
Timing May Matter: Early Intracranial Radiotherapy Associated with Improved Survival in Breast Cancer Brain Metastases
Speaker: Mishaal Munir, MD, MBBS, BSC - Miami Cancer Institute: Baptist Health South Florida, Miami -
01:20pm - 01:30pm ET
Uncertainty Quantification-Incorporated Ensemble Model for Personalized Prediction of Severe Radiotherapy-Induced Lymphopenia among Esophagus Cancer Patients
Speaker: Baode Gao, MS - University of Texas Health Science Center at Houston, Houston -
01:30pm - 01:40pm ETSpeaker: Reid Thompson, MD, PhD - Oregon Health & Science University, Portland